Document is current
Any future updates will be listed below
-
Authors
Rafii, Michael S. https://orcid.org/0000-0003-2640-2094
Aisen, Paul S. https://orcid.org/0000-0002-2896-5838
- License Information
-
More Information
Article History
Accepted: 3 July 2025
First Online: 21 July 2025
Competing interests
: M.S.R. is employed by the University of Southern California and the Alzheimer’s Therapeutics Research Institute (ATRI) and has received grants or contracts from Eisai and Eli Lilly, which were paid to his institution. He has received consulting fees from AC Immune and Ionis. He has participated on a data safety monitoring board or an advisory board for Alzheon, Alnylam, Biohaven, Embic, Prescient Imaging, Positrigo and Recall Therapeutics. P.S.A. has research grants from the National Institutes of Health, Eli Lilly and Eisai, and consults with Merck, Roche, BMS, Genentech, Abbvie, Biogen, ImmunoBrain Checkpoint, Arrowhead, AltPep and Neurimmune.
